Trials / Completed
CompletedNCT04695314
Foot Reflexology in Ocular Hypertensive and Glaucoma Patients
Effect of Foot Reflexology on Intraocular Pressure in Ocular Hypertensive and Glaucoma Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Temple University · Academic / Other
- Sex
- All
- Age
- 30 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
To determine the effect of foot reflexology in primary open angle glaucoma (POAG) patients and the effect of a shoe insert to perform continuous foot reflexology in ocular hypertensive (OHTN) patients.
Detailed description
This is a prospective pilot study in glaucoma patients and a prospective therapeutic trial in ocular hypertensive patients. Patients were recruited from the Temple Ophthalmology outpatient clinic. Primary open-angle glaucoma patients were recruited from those about to have SLT for additional intraocular pressure (IOP) lowering. OHTN patients were recruited from the clinic. The glaucoma patients performed a 5-minute foot massage on a foot massage board and the IOP was checked pre-massage, post-massage and 30, 60, 90 and 120 min post massage. OHTN patients underwent a one-month drop washout and then performed a 5-minute massage using a 3D-printed shoe insert with the identical pressure checks. They then were randomly assigned to wear the shoe insert or a sham insert for one day. IOP was checked before inserting the insert and at the end of the day. The number of steps was recorded each day.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Massage | Foot reflexology board (JAPAN TSUBO HH-700) with massage focused at the base of the second and third toes |
| PROCEDURE | Experimental insert | Raised shoe insert, insert used for massage |
| PROCEDURE | Sham insert | Flat shoe insert, insert used for massage |
Timeline
- Start date
- 2017-11-07
- Primary completion
- 2020-11-18
- Completion
- 2020-11-18
- First posted
- 2021-01-05
- Last updated
- 2021-02-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04695314. Inclusion in this directory is not an endorsement.